Keywords: forest, gains, af102b, license, usa, laboratories, licensed

FOREST GAINS AF102B LICENSE FOR USA

Article | 06 September 1993

Print This

Forest Laboratories has licensed the exclusive rights for the USA to AF102B, a muscarinic agonist, from the pharmaceutical division ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in